enrofloxacin has been researched along with Staphylococcal Infections in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Kadlec, K; Schwarz, S | 1 |
| Adil, M; Ajmal, M; Ali, MM; Aqib, AI; Cui, K; Khan, A; Liang, Q; Liu, Q; Pan, H; Qin, C; Saleem, A; Sarwar, Z; Shafique, L | 1 |
| da Costa, MM; da Costa, SL; de Barros, M; de Castro, LK; Guimarães, SHS; Lima, MC; Moreira, MAS; Polveiro, RC; Scatamburlo, TM | 1 |
| Chen, D; Li, Z; Liu, Y; Luo, W; Pan, Y; Qu, W; Xiao, M; Xie, S; Zhang, A | 1 |
| Da Silva Lopes, I; Granja, MMC; Lima, MC; Moreira, MAS; Polveiro, RC; Roldão, TCB; Vidigal, PMP | 1 |
| Odoi, A; Oguttu, JW; Qekwana, DN; Sithole, F | 1 |
| Kim, Y; Kweon, MN; Lee, SH; Lee, YS; Park, YY; Yang, JY | 1 |
| Boroojeni, AM; Marzban, M; Mohammadi, M; Mosleh, N; Namazi, F; Shomali, T | 1 |
| Gibson, TW; Nazarali, A; Rousseau, J; Singh, A; Walker, M; Weese, JS | 1 |
| Billerbeck, C; Fessler, AT; Hauschild, T; Kadlec, K; Kaspar, H; Mankertz, J; Schwarz, S; Wendlandt, S | 1 |
| Hulland, C; Langoni, H; Oliveira, L; Ruegg, PL | 1 |
| Boerman, OC; Dierckx, R; Rennen, HJ; Siaens, RH; Slegers, G | 1 |
| Baş, AL; Corlu, M; Erganiş, O; Simşek, A | 1 |
| Halling-Sørensen, B; Jensen, LB; Lykkeberg, AK | 1 |
| McClure, JT; Meinen, JB; Rosin, E | 1 |
| Anderson, MA; Branson, KR; Mann, FA; Pope, ER | 1 |
| Farca, AM; Maffei, F; Piromalli, G; Re, G | 1 |
| Pyörälä, EO; Pyörälä, SH | 1 |
| André-Fontaine, G; Ganière, JP; Limet, A; Médaille, C; Ruvoen, N | 1 |
| Bjorling, D; Fialkowski, JP; Lautzenhiser, SJ; Rosin, E | 1 |
| Bas, L; Deĝim, T; Deĝim, Z; Elmas, M | 1 |
1 trial(s) available for enrofloxacin and Staphylococcal Infections
| Article | Year |
|---|---|
Comparative evaluation of therapeutic efficacy of sulfadiazine-trimethoprim, oxytetracycline, enrofloxacin and florfenicol on Staphylococcus aureus-induced arthritis in broilers.
Topics: Animals; Anti-Bacterial Agents; Arthritis; Chickens; Drug Combinations; Enrofloxacin; Female; Fluoroquinolones; Male; Oxytetracycline; Poultry Diseases; Staphylococcal Infections; Staphylococcus aureus; Sulfadiazine; Thiamphenicol; Treatment Outcome; Trimethoprim | 2016 |
20 other study(ies) available for enrofloxacin and Staphylococcal Infections
| Article | Year |
|---|---|
Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; DNA Transposable Elements; Female; Methicillin; Molecular Sequence Data; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Swine; Swine Diseases; Trimethoprim Resistance | 2010 |
Genomic and Therapeutic Analyses of
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cattle; Endometritis; Enrofloxacin; Female; Genomics; Gentamicins; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Profiles of Staphyloccocus aureus isolated from goat persistent mastitis before and after treatment with enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enrofloxacin; Female; Gene Expression Regulation, Bacterial; Goat Diseases; Goats; Mastitis; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Staphylococcal Infections; Staphylococcus aureus; Virulence; Virulence Factors | 2020 |
Composite inclusion complexes containing hyaluronic acid/chitosan nanosystems for dual responsive enrofloxacin release.
Topics: Anti-Bacterial Agents; Chitosan; Cyclodextrins; Drug Carriers; Drug Liberation; Enrofloxacin; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Nanogels; Poloxamer; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Multilocus sequence analysis reveals genetic diversity in Staphylococcus aureus isolate of goat with mastitis persistent after treatment with enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Brazil; Drug Resistance, Bacterial; Enrofloxacin; Female; Genetic Variation; Geography; Goat Diseases; Goats; Mastitis; Microbial Sensitivity Tests; Milk; Multilocus Sequence Typing; Phylogeny; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Dog Diseases; Dogs; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Hospitals, Animal; Kanamycin; Lincomycin; Male; Retrospective Studies; South Africa; Spectinomycin; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Tylosin | 2017 |
The resident pathobiont Staphylococcus xylosus in Nfkbiz-deficient skin accelerates spontaneous skin inflammation.
Topics: Adaptor Proteins, Signal Transducing; Animals; CD4-Positive T-Lymphocytes; Cephalexin; Dermatitis; Disease Models, Animal; Enrofloxacin; Humans; Immunoglobulin E; Mice; Nuclear Proteins; Sequence Analysis, DNA; Skin; Staphylococcal Infections; Staphylococcus; Symbiosis | 2017 |
Evaluation of the Impact of Methicillin-Resistant Staphylococcus pseudintermedius Biofilm Formation on Antimicrobial Susceptibility.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Canada; Cefazolin; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Gentamicins; Methicillin Resistance; Plankton; Staphylococcal Infections; Staphylococcus; United States | 2016 |
Target gene mutations among methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus with elevated MICs of enrofloxacin obtained from diseased food-producing animals or food of animal origin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Food Microbiology; Microbial Sensitivity Tests; Mutation, Missense; Point Mutation; Promoter Regions, Genetic; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Minimum inhibitory concentrations of Staphylococcus aureus recovered from clinical and subclinical cases of bovine mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Resistance, Bacterial; Enrofloxacin; Female; Fluoroquinolones; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin.
Topics: Animals; Candida albicans; Candidiasis; Ciprofloxacin; Enrofloxacin; Fluoroquinolones; Organotechnetium Compounds; Quinolones; Radionuclide Imaging; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Technetium; Thigh | 2004 |
Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Carriers; Enrofloxacin; Fluoroquinolones; Liposomes; Male; Monocytes; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2005 |
Susceptibility of bacteria isolated from pigs to tiamulin and enrofloxacin metabolites.
Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Bacterial Agents; Diterpenes; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Sewage; Staphylococcal Infections; Staphylococcus aureus; Swine; Swine Diseases | 2007 |
Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections.
Topics: Animals; Anti-Infective Agents; Biotransformation; Cyclophosphamide; Dogs; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Male; Metabolic Clearance Rate; Mice; Mice, Inbred ICR; Neutropenia; Quinolones; Species Specificity; Staphylococcal Infections | 1995 |
Use of an ultrasonic Doppler flow detector for determining tissue viability in a dog.
Topics: Animals; Anti-Infective Agents; Arteries; Bone Wires; Cefadroxil; Dogs; Enrofloxacin; Female; Fluoroquinolones; Forelimb; Fractures, Bone; Pseudomonas Infections; Quinolones; Regional Blood Flow; Staphylococcal Infections; Tissue Survival; Toes; Ultrasonography, Doppler; Wound Infection | 1994 |
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine | 1997 |
Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995).
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cell Count; Enrofloxacin; Enterobacteriaceae Infections; Female; Fluoroquinolones; Follow-Up Studies; Mastitis, Bovine; Milk; Penicillin G Procaine; Penicillins; Quinolones; Retrospective Studies; Spiramycin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 1998 |
Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Pyoderma; Quinolones; Staphylococcal Infections; Staphylococcus | 2001 |
In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Drug Combinations; Drug Synergism; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2001 |
The use of liposomal enrofloxacin for intracellular infections in Kangal dogs and visualization of phagocytosis of liposomes.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Dog Diseases; Dogs; Drug Carriers; Enrofloxacin; Fluoroquinolones; Liposomes; Macrophages; Monocytes; Neutrophils; Phagocytosis; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2002 |